Issue 8

Growth forecasts for orphan drugs slow and AZ’s CEO calls out Europe

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Will Pharma Companies Continue to Adopt Orphan Drugs? 

A report recently published by Evaluate titled “Are Orphan Drugs Losing Their Sparkle” might sound apprehensive, but it highlights why pharma companies can still expect plenty of promise and activity within the orphan drug sector. 

Read more here.

FEATURED STORIES

Adare Adds to High Potency Capabilities in Europe and the US 

Read more here.

Bristol Myers Squibb's Sign $380 mn Deal with Cellares to Expand Cell Therapy Access

Read more here.

Lilly Expedites Injectable Medicine Production Through Facility Acquisition Dealmaking 

Read more here.

FDA Approves Lumicell's Innovative Imaging System for Enhancing Breast Cancer Surgery

Read more here.

Research Shows That Aspirin Could Help Prevent Colon Cancer

Read more here.

Takeda, Astellas, and SMBC Launch Strategic Alliance for Drug Discovery

Read more here.

Mundipharma and Vectura to Develop Environment-Friendly Flutiform Inhaler 

Read more here.

Pathios Therapeutics Raises BMS-led Series B Funding

Read more here.

Nanoform Completed New Share Issue to Raise 15.4 mn Euros

Read more here.

Teva and Alvotech Set to Transform Humira Market with Simlandi FDA Approval

Read more here.

Novartis Surpasses Q1 Expectations, Raises Full-Year Outlook on Strong Drug Sales

Read more here.

Regeneron and Mammoth Biosciences Forge $100 mn Gene Editing Collaboration

Read more here.